Nurix Therapeutics (Nasdaq: NRIX) announced it has earned a $10 million milestone payment after its collaborator Sanofi initiated a Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE